Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Management decisions regarding end patent strategies in the South African private pharmaceutical market
Dissertation (MBA)--University of Pretoria, 2013.
Saved in:
| Other Authors: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
University of Pretoria
2014
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867613517729759233 |
|---|---|
| access_status_str | Open Access |
| author2 | Holland, Mike |
| author_browse | Holland, Mike |
| author_facet | Holland, Mike |
| collection | Thesis |
| dc_rights_str_mv | © 2014 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria |
| description | Dissertation (MBA)--University of Pretoria, 2013. |
| format | Thesis |
| id | oai:repository.up.ac.za:2263/41894 |
| institution | University of Pretoria (South Africa) |
| language | English |
| last_indexed | 2026-06-10T12:37:24.815Z |
| license_str | Other — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from UPSpace — University of Pretoria Institutional Repository |
| publishDate | 2014 |
| publishDateRange | 2014 |
| publishDateSort | 2014 |
| publisher | University of Pretoria |
| publisherStr | University of Pretoria |
| record_format | dspace |
| source_str | UPSpace — University of Pretoria Institutional Repository |
| spelling | oai:repository.up.ac.za:2263/41894 Management decisions regarding end patent strategies in the South African private pharmaceutical market Holland, Mike ichelp@gibs.co.za Barron, Paul UCTD Decision making-- pharmaceutical industry Drugs -- South Africa -- Patent Pharmaceutical industry Dissertation (MBA)--University of Pretoria, 2013. The loss of patent protection for a pharmaceutical product is a significant event for manufacturers. Although this phenomenon has been occurring in the industry for decades, it has been of increased interest during the past few years due to the much publicised “patent cliff” experienced by a number of major pharmaceutical manufacturers. Recent developments in emerging economies such as India and South Africa have brought the concept of intellectual property rights under review. The traditional approach to extend market exclusivity through the use of secondary patents is no longer valid. New product strategies are now required to transition from a patent protected market to an open market. This study adds to the current literature by investigating post-patent strategies pursued in the South African private pharmaceutical market. The primary focus was to determine the rationale behind choosing a particular strategy. This study, exploratory in nature and structured around five propositions, investigated strategies to manage the patent expiry and potential entry from generic competitors. These included manipulating price, increasing promotion, developing value adding product extensions or launching a clone. Information was gathered through 14 interviews with product managers responsible for implementing the chosen strategy. The interviews were conducted using a structured questionnaire as well as open-ended questions. Five companies were selected for the study using purposive sampling and each company then self-selected which products would be discussed. The most pursued strategy for the sample was to launch a clone. This allowed the manufacturer to compete with lower priced generics using the clone as well as continue to profit from the remaining brand loyal, price insensitive consumers with the original product. The price of the original product was not used to deter entry or compete with generic products. Profit-maximising behaviour was exhibited by the reduction in advertising and promotional spend after patent expiry. When available, the use of product extensions to extend market exclusivity continued to be a preferred strategy. zkgibs2014 Gordon Institute of Business Science (GIBS) MBA Unrestricted 2014-09-02T12:55:28Z 2014-09-02T12:55:28Z 2014-04-30 2013 Mini Dissertation Barron, P 2013, Management decisions regarding end patent strategies in the South African private pharmaceutical market, MBA Mini Dissertation, University of Pretoria, Pretoria, viewed yymmdd <http://hdl.handle.net/2263/41894> http://hdl.handle.net/2263/41894 en © 2014 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria application/pdf University of Pretoria |
| spellingShingle | UCTD Decision making-- pharmaceutical industry Drugs -- South Africa -- Patent Pharmaceutical industry Management decisions regarding end patent strategies in the South African private pharmaceutical market |
| title | Management decisions regarding end patent strategies in the South African private pharmaceutical market |
| title_full | Management decisions regarding end patent strategies in the South African private pharmaceutical market |
| title_fullStr | Management decisions regarding end patent strategies in the South African private pharmaceutical market |
| title_full_unstemmed | Management decisions regarding end patent strategies in the South African private pharmaceutical market |
| title_short | Management decisions regarding end patent strategies in the South African private pharmaceutical market |
| title_sort | management decisions regarding end patent strategies in the south african private pharmaceutical market |
| topic | UCTD Decision making-- pharmaceutical industry Drugs -- South Africa -- Patent Pharmaceutical industry |
| url | http://hdl.handle.net/2263/41894 |